Related Experiment Video
Updated: May 2, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Triptolide induces s phase arrest and apoptosis in gallbladder cancer cells
Yun-Ping Hu1, Zhu-Jun Tan1, Xiang-Song Wu1
1Institute of Biliary Tract Disease, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China.
Abstract:
Gallbladder carcinoma is the most common malignancy of the biliary tract, with a very low 5-year survival rate and extremely poor prognosis. Thus, new effective treatments and drugs are urgently needed for the treatment of this malignancy. In this study, for the first time we investigated the effects of triptolide on gallbladder cancer cells and identified the mechanisms underlying its potential anticancer effects. The MTT assay showed that triptolide decreased cell viability in a dose- and time-dependent manner. The results of the colony formation assay indicated that triptolide strongly suppressed colony formation ability in GBC-SD and SGC-996 cells. Flow cytometric analysis revealed that triptolide induced S phase arrest in gallbladder cancer cells. In addition, triptolide induced apoptosis, as shown by the results of annexin V/propidium iodide double-staining and Hoechst 33342 staining. Furthermore, triptolide decreased mitochondrial membrane potential (ΔΨm) in a dose-dependent manner. Finally, western blot analysis of triptolide-treated cells revealed the activation of caspase-3, caspase-9, PARP, and Bcl-2; this result demonstrated that triptolide induced apoptosis in gallbladder cancer cells by regulating apoptosis-related protein expression, and suggests that triptolide may be a promising drug to treat gallbladder carcinoma.
Insights
Triptolide effectively inhibits gallbladder cancer cell growth and survival. This natural compound induces cell cycle arrest and apoptosis, suggesting its potential as a novel gallbladder carcinoma treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Gallbladder carcinoma has a poor prognosis and limited treatment options.
- New therapeutic strategies are urgently needed for this malignancy.
Purpose of the Study:
- To investigate the anticancer effects of triptolide on gallbladder cancer cells.
- To elucidate the underlying mechanisms of triptolide's action.
Main Methods:
- MTT assay for cell viability.
- Colony formation assay for cell proliferation.
- Flow cytometry for cell cycle analysis and apoptosis.
- Western blot for apoptosis-related protein expression.
Main Results:
- Triptolide reduced gallbladder cancer cell viability and colony formation.
- Triptolide induced S phase arrest and apoptosis.
- Triptolide decreased mitochondrial membrane potential and modulated apoptosis-related proteins (caspase-3, caspase-9, PARP, Bcl-2).
Conclusions:
- Triptolide exhibits significant anticancer activity against gallbladder cancer cells.
- Triptolide induces apoptosis through the regulation of key proteins.
- Triptolide shows promise as a potential therapeutic agent for gallbladder carcinoma.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
The Intrinsic Apoptotic Pathway